Dr. Anil Gupta is one of the most prominent and dynamic clinical oncologist and radiation oncologist in Delhi NCR with international repute. Presently, he is working at at Subharti Institute of Cancer Management and Research in Meerut and Clinic at Eta 1 in Greater Noida.
Dr. Anil has a vast experience of working at almost all leading high volume cancer institutes of India including All India Institute of Medical Sciences(AIIMS), New Delhi; Institute of Liver and Biliary Sciences, New Delhi; Post Graduate Institute of Medical Education and Research(PGIMER), Chandigarh and PARK Group of Hospitals, Sonepat, Panipat, Gurgaon.
Dr. Anil Gupta has pioneered innovative treatment techniques for addressing moving tumors, employing advanced methodologies such as the breath-hold technique, respiratory gating, and tumor tracking. These cutting-edge approaches enable precise targeting and delivery of therapy, even in dynamic and challenging tumor environments.
He did M.B.B.S from M.S Ramaiah Medical College, Bangalore in 2007 to 2012
He did MD from Post Graduate Institute of Medical Education and Research, Chandigarh from 2015 to 2017. It is a premiere institute for post graduate medical education in India.
He did his Senior residency from ILBS New Delhi in the period of 2018 to 2019 and AIIMS, New Delhi in the period of 2019 to 2022.
He did his observership in proton therapy and particle therapy from Heidelberg Ion Therapy Center (HIT), Germany in the year 2022.
Book appointment by calling or messaging at +919625433914
Dr. Anil Gupta at Radiation Oncology provides cutting-edge radiation therapy services with a focus on precision and compassion. Dr. Gupta targets cancer cells while minimizing exposure to healthy tissues. His approach aims to effectively destroy cancerous cells, reduce side effects, and improve patients' quality of life during treatment.
Dr. Anil Gupta offers advanced diagnostic services for various types of cancer, ensuring precise and timely detection. Dr. Gupta identifies cancer at its earliest stages. This comprehensive diagnostic approach provides accurate staging and characterization of tumors, guiding the development of personalized treatment plans.
Dr. Gupta offers pioneering treatment options using advanced proton and carbon ion therapy. These therapies provide precise and powerful radiation that targets tumors, especially those in difficult-to-treat areas. Proton and carbon ion therapy deliver maximum energy to the tumor site, reducing side effects and improving outcomes.
Dr. Gupta offers advanced targeted therapy options, focusing on precision and a personalized treatment approach. Targeted therapy uses medications designed to interfere with specific molecules involved in cancer growth.
Immunotherapy has emerged as a revolutionary approach in the field of oncology, harnessing the power of the body's immune system to fight cancer. Unlike traditional cancer treatments like chemotherapy and radiation therapy, which directly target cancer cells, immunotherapy works by stimulating the immune system to recognize and destroy cancer cells more effectively.
Some patients may find it difficult to visit the hospital for their treatment. For these patients, care can be provided in the comfort of their own home, ensuring they receive the necessary medical attention without the need for travel.
Stereotactic Ablative Body Radiotherapy (SABR/SBRT) has established its role in liver cancer, but pe...
A welcome initiative to promote cancer prevention, detection, treatment, and care for Indo-pacific r...
Lymphoma is a type of cancer that affects the lymphatic system, which is a crucial part of your immu...
Comprehensive cancer treatment is a multidisciplinary approach where specialists work together to di...
We recently treated a middle-aged patient diagnosed with EGFR Del19 mutated stage IVa adenocarcino...
Gynecological malignancies, including cancers of the cervix, ovaries, and uterus, represent a signif...
Gynaecological malignancies, including cancers of the cervix, ovaries, and uterus, represent a signi...
Introduction This study aims to quantitatively assess eligible patients and project the demand for p...